Variant report

Variant	esv3436552
Chromosome Location	chr7:4997451-5000999
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr7:4998180-4998496	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr7:4998357-4998409	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD2	chr7:4998371-4998472	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr7:5000040-5000190	BE2_C	brain:	n/a	chr7:5000059-5000072
5	CTCF	chr7:5000060-5000210	GM06990	blood:	n/a	n/a
6	CTCF	chr7:5000060-5000210	HVMF	connective:	n/a	n/a
7	CTCF	chr7:5000040-5000190	HUVEC	blood vessel:	n/a	chr7:5000059-5000072
8	CTCF	chr7:5000020-5000170	NB4	blood:	n/a	chr7:5000059-5000072
9	CTCF	chr7:5000020-5000170	WERI-Rb-1	eye:	n/a	chr7:5000059-5000072
10	CTCF	chr7:5000000-5000150	GM12878	blood:	n/a	chr7:5000059-5000072
11	CTCF	chr7:4999936-5000196	GM12878	blood:	n/a	chr7:5000059-5000072
12	CTCF	chr7:4999900-5000170	HFF-Myc	foreskin:	n/a	chr7:5000059-5000072
13	CTCF	chr7:5000040-5000190	Caco-2	colon:	n/a	chr7:5000059-5000072
14	CTCF	chr7:5000020-5000170	HMEC	breast:	n/a	chr7:5000059-5000072
15	CTCF	chr7:4999960-5000110	BE2_C	brain:	n/a	chr7:5000059-5000072
16	CTCF	chr7:5000060-5000210	HCPEpiC	choroid plexus:	n/a	n/a
17	CTCF	chr7:5000040-5000190	AG09309	skin:	n/a	chr7:5000059-5000072
18	CTCF	chr7:4999991-5000183	GM12891	blood:	n/a	chr7:5000059-5000072
19	CTCF	chr7:5000020-5000170	HPAF	blood vessel:	n/a	chr7:5000059-5000072
20	CTCF	chr7:4998100-4998250	GM12866	blood:	n/a	n/a
21	CTCF	chr7:5000020-5000170	HEK293	kidney:	n/a	chr7:5000059-5000072
22	CTCF	chr7:5000000-5000150	WERI-Rb-1	eye:	n/a	chr7:5000059-5000072
23	CTCF	chr7:5000040-5000190	NHEK	skin:	n/a	chr7:5000059-5000072
24	CTCF	chr7:5000020-5000170	HCPEpiC	choroid plexus:	n/a	chr7:5000059-5000072
25	CTCF	chr7:4999980-5000130	GM06990	blood:	n/a	chr7:5000059-5000072
26	CTCF	chr7:5000000-5000150	HCFaa	heart:	n/a	chr7:5000059-5000072
27	CTCF	chr7:5000053-5000120	HUVEC	blood vessel:	n/a	chr7:5000059-5000072
28	CTCF	chr7:5000026-5000166	GM12878	blood:	n/a	chr7:5000059-5000072
29	CTCF	chr7:5000040-5000190	HPAF	blood vessel:	n/a	chr7:5000059-5000072
30	CTCF	chr7:5000000-5000150	HFF	foreskin:	n/a	chr7:5000059-5000072
31	CTCF	chr7:4999892-5000154	T-47D	breast:	n/a	chr7:5000059-5000072
32	CTCF	chr7:5000080-5000230	HEEpiC	esophagus:	n/a	n/a
33	CTCF	chr7:5000020-5000170	HMF	breast:	n/a	chr7:5000059-5000072
34	CTCF	chr7:5000020-5000170	HFF-Myc	foreskin:	n/a	chr7:5000059-5000072
35	CTCF	chr7:4999934-5000266	T-47D	breast:	n/a	chr7:5000059-5000072
36	CTCF	chr7:5000020-5000170	RPTEC	kidney:	n/a	chr7:5000059-5000072
37	JUND	chr7:4998289-4998381	H1-hESC	embryonic stem cell:	n/a	n/a
38	MYC	chr7:5000035-5000086	MCF-7	breast:	n/a	n/a
39	POLR2A	chr7:4999998-5000067	MCF-7	breast:	n/a	n/a
40	POLR2A	chr7:4999995-5000111	MCF-7	breast:	n/a	n/a
41	POLR2A	chr7:4998159-4998256	H1-hESC	embryonic stem cell:	n/a	n/a
42	POLR2A	chr7:5000737-5000884	H1-hESC	embryonic stem cell:	n/a	n/a
43	POLR2A	chr7:4998037-4998323	K562	blood:	n/a	n/a
44	RAD21	chr7:4999856-5000176	ECC-1	luminal epithelium:	n/a	chr7:5000059-5000073
45	RAD21	chr7:4999832-5000225	ECC-1	luminal epithelium:	n/a	chr7:5000059-5000073
46	RCOR1	chr7:4997594-4997623	Hela-S3	cervix:	n/a	n/a
47	ZNF143	chr7:4998019-4998425	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:4998714-4998764	BJ	skin:	n/a
2	chr7:4998415-4998465	Hepatocyte	liver:	n/a
3	chr7:5000219-5000269	NHDF-neo	bronchial:	n/a
4	chr7:4998094-4998144	Caco-2	colon:	n/a
5	chr7:4998714-4998764	NB4	blood:	n/a
6	chr7:4998714-4998764	ProgFib	skin:	n/a
7	chr7:5000219-5000269	GM12891	blood:	n/a
8	chr7:5000111-5000161	SK-N-SH	brain:	n/a
9	chr7:5000111-5000161	AG09319	gingival:	n/a
10	chr7:4998094-4998144	HCPEpiC	choroid plexus:	n/a
11	chr7:4998649-4998699	ProgFib	skin:	n/a
12	chr7:4998714-4998764	PFSK-1	brain:	n/a
13	chr7:4998415-4998465	Jurkat	blood:	n/a
14	chr7:4998714-4998764	SKMC	muscle:	n/a
15	chr7:4998649-4998699	GM06990	blood:	n/a
16	chr7:4998094-4998144	MCF10A-Er-Src	breast:	n/a
17	chr7:4998714-4998764	GM12891	blood:	n/a
18	chr7:4998649-4998699	H1-hESC	embryonic stem cell:	embryo
19	chr7:4998045-4998095	AG04450	lung:	fetal
20	chr7:4998714-4998764	HCM	heart:	n/a
21	chr7:4998045-4998095	NB4	blood:	n/a
22	chr7:4998094-4998144	HCF	heart:	n/a
23	chr7:5000219-5000269	AG09319	gingival:	n/a
24	chr7:4998415-4998465	HRE	kidney:	n/a
25	chr7:5000111-5000161	IMR90	lung:	fetal
26	chr7:4998649-4998699	AoSMC	blood vessel:	n/a
27	chr7:4998415-4998465	HIPEpiC	eye:	n/a
28	chr7:4998649-4998699	Hepatocyte	liver:	n/a
29	chr7:4998045-4998095	Hepatocyte	liver:	n/a
30	chr7:4998045-4998095	A549	lung:	n/a
31	chr7:4998094-4998144	SK-N-MC	brain:	n/a
32	chr7:4998094-4998144	AG09319	gingival:	n/a
33	chr7:4998094-4998144	NH-A	brain:	n/a
34	chr7:5000219-5000269	HAEpiC	amniotic membrane:	n/a
35	chr7:4998094-4998144	ProgFib	skin:	n/a
36	chr7:4998094-4998144	HepG2	liver:	n/a
37	chr7:4998649-4998699	HCM	heart:	n/a
38	chr7:4998714-4998764	GM19239	blood:	n/a
39	chr7:4998649-4998699	Hela-S3	cervix:	n/a
40	chr7:4998045-4998095	AoSMC	blood vessel:	n/a
41	chr7:4998649-4998699	HNPCEpiC	eye:	n/a
42	chr7:4998470-4998520	PANC-1	pancreas:	n/a
43	chr7:4998714-4998764	LNCaP	prostate:	n/a
44	chr7:4998415-4998465	MCF10A-Er-Src	breast:	n/a
45	chr7:4998714-4998764	AoSMC	blood vessel:	n/a
46	chr7:4998415-4998465	MCF-7	breast:	n/a
47	chr7:5000219-5000269	K562	blood:	n/a
48	chr7:4998045-4998095	MCF10A-Er-Src	breast:	n/a
49	chr7:4998649-4998699	HCF	heart:	n/a
50	chr7:4998094-4998144	GM12891	blood:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:5000124..5001872-chr7:5003640..5006616,2	K562	blood:

Variant related genes	Relation type
MMD2	TF binding region
MMD2	CpG island

Extended variants
information (count: 165 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:165 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs540270833	chr7:4997472-4997473	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs74957485	chr7:4997481-4997482	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs564730562	chr7:4997490-4997491	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs55881424	chr7:4997549-4997550	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs550713411	chr7:4997613-4997614	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs150606722	chr7:4997621-4997622	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs529945700	chr7:4997689-4997690	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs367742120	chr7:4997702-4997703	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs56311253	chr7:4997746-4997747	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs557903569	chr7:4997760-4997761	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs566796267	chr7:4997769-4997770	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs73328942	chr7:4997804-4997805	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs558861974	chr7:4997813-4997814	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs77179879	chr7:4997848-4997849	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs577695582	chr7:4997853-4997854	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs537913935	chr7:4997865-4997866	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs78804436	chr7:4997892-4997893	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs191116374	chr7:4997908-4997909	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs111550239	chr7:4997909-4997910	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs542451326	chr7:4997939-4997940	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs11768053	chr7:4998026-4998027	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs572652236	chr7:4998043-4998044	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs2942549	chr7:4998143-4998144	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
24	rs77659906	chr7:4998146-4998147	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs532169412	chr7:4998217-4998218	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs375139797	chr7:4998227-4998228	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs73044291	chr7:4998231-4998232	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs562604173	chr7:4998232-4998233	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs573079715	chr7:4998240-4998241	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs548408413	chr7:4998257-4998258	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs528294540	chr7:4998275-4998276	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs566550078	chr7:4998278-4998279	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs531384227	chr7:4998297-4998298	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs527539999	chr7:4998374-4998375	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs540093440	chr7:4998376-4998377	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs369939195	chr7:4998407-4998408	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs73673227	chr7:4998440-4998441	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs556230224	chr7:4998450-4998451	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs559848189	chr7:4998466-4998467	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs568262335	chr7:4998480-4998481	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs112778124	chr7:4998523-4998524	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs377552330	chr7:4998582-4998583	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs187126919	chr7:4998616-4998617	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs540100872	chr7:4998636-4998637	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs558518080	chr7:4998650-4998651	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs191988809	chr7:4998710-4998711	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs373516195	chr7:4998713-4998714	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs551509171	chr7:4998782-4998783	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs183424925	chr7:4998791-4998792	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs555378993	chr7:4998815-4998816	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Lynch syndrome	22585707	CNVD
Follicular lymphoma	20505157	CNVD
Breast cancer	16397240	CNVD
Raine Syndrome	17924334	CNVD
Diffuse large b-cell lymphoma	21266526	CNVD
Melanoma	18172304	CNVD
Sudden cardiac death	19188705	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Glioma	18556773	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Ovarian cancer	22174824	CNVD
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Urothelial carcinoma	21177765	CNVD
Glioblastoma multiforme	21525872	CNVD
Bladder cancer	21909424	CNVD
Myelofibrosis	22110671	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	21045282	CNVD
Disorders of sex development	21048976	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:178 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:4990200-4998200	Weak transcription	Right Atrium	heart
2	chr7:4997200-4998000	Active TSS	Brain Hippocampus Middle	brain
3	chr7:4997200-4998000	Enhancers	Spleen	Spleen
4	chr7:4997200-4998800	Active TSS	Brain Anterior Caudate	brain
5	chr7:4997400-4997600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
6	chr7:4997400-4997600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
7	chr7:4997400-4997600	Active TSS	Brain Angular Gyrus	brain
8	chr7:4997400-4997800	Active TSS	Brain Inferior Temporal Lobe	brain
9	chr7:4997400-4998000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr7:4997400-4998000	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
11	chr7:4997400-4998000	Bivalent Enhancer	Stomach Smooth Muscle	stomach
12	chr7:4997400-4998200	Active TSS	Brain Cingulate Gyrus	brain
13	chr7:4997400-4998200	Bivalent/Poised TSS	Brain Germinal Matrix	brain
14	chr7:4997400-4998200	Active TSS	Brain Substantia Nigra	brain
15	chr7:4997400-4998400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
16	chr7:4997400-4998800	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
17	chr7:4997600-4997800	Flanking Active TSS	Brain Angular Gyrus	brain
18	chr7:4997600-4998200	Bivalent Enhancer	Fetal Brain Male	brain
19	chr7:4997600-4998200	Bivalent/Poised TSS	Fetal Brain Female	brain
20	chr7:4997600-4998200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
21	chr7:4997600-4998400	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
22	chr7:4997600-4998400	Bivalent Enhancer	Fetal Muscle Leg	muscle
23	chr7:4997600-4998600	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
24	chr7:4997600-4999200	Bivalent/Poised TSS	Psoas Muscle	Psoas
25	chr7:4997800-4998000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
26	chr7:4997800-4998000	Active TSS	Brain Angular Gyrus	brain
27	chr7:4997800-4998200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
28	chr7:4997800-4998800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
29	chr7:4997800-4998800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
30	chr7:4997800-4998800	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
31	chr7:4998000-4998200	Bivalent/Poised TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr7:4998000-4998200	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
33	chr7:4998000-4998200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr7:4998000-4998200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr7:4998000-4998200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
36	chr7:4998000-4998200	Bivalent Enhancer	Colon Smooth Muscle	Colon
37	chr7:4998000-4998200	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
38	chr7:4998000-4998200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
39	chr7:4998000-4998200	Bivalent Enhancer	Ovary	ovary
40	chr7:4998000-4998200	Enhancers	Pancreas	Pancrea
41	chr7:4998000-4998200	Flanking Bivalent TSS/Enh	Rectal Smooth Muscle	rectum
42	chr7:4998000-4998200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
43	chr7:4998000-4998200	Bivalent Enhancer	Spleen	Spleen
44	chr7:4998000-4998200	Bivalent Enhancer	NH-A	brain
45	chr7:4998000-4998400	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
46	chr7:4998000-4998400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
47	chr7:4998000-4998400	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
48	chr7:4998000-4998400	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
49	chr7:4998000-4998400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr7:4998000-4998400	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links